Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
This study is conducted to test the hypothesis that in type 2 diabetic adults with fatty
liver who are resistant to metformin, treatment with liraglutide in combination with
metformin will cause an absolute reduction in liver fat superior to insulin-metformin
treatment within a 3-month period, as measured by magnetic resonance imaging (MRI).
Phase:
Phase 2
Details
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborators:
Canadian Heads of Academic Radiology-GE Healthcare Development Award Centre de Recherche du Centre Hospitalier de l'Université de Montréal Diabetes Québec Radiological Society of North America